We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > ephedrine

News List

FDA Approves Rezipres (ephedrine hydrochloride injection) for Hypotension During Anesthesia drugs
June 16, 2021
Eton Pharmaceuticals, Inc (Nasdaq: ETON) today announced that FDA has approved Rezipres (ephedrine hydrochloride injection) for the treatment of clinically important hypotension occurring in the setting of anesthesia.
Nexus Pharmaceuticals announces approval of Emerphed injection pharmaceutical-business-review
April 26, 2020
Nexus Pharmaceuticals announced that has received U.S. Food and Drug Administration (FDA) approval for its patent-pending New Drug Application (NDA) Emerphed, the first and only premixed ephedrine in a ready-to-use 50 mg/10 mL vial.